Introduction to Astatine
Astatine (symbol At, atomic number 85) is a chemical element positioned in Group 17, the halogens, of the periodic table. It is the heaviest known halogen and exhibits properties that are expected to be intermediate between iodine and polonium. Astatine is a highly radioactive element, and all its known isotopes are unstable, decaying rapidly. Its name originates from the Greek word “astatos,” meaning unstable.
Natural Occurrence on Earth
Astatine is the rarest naturally occurring element on Earth’s crust, with an estimated total quantity present at any given time being less than one gram. It does not exist in concentrated deposits but is formed in extremely minute quantities as an intermediate decay product in the natural radioactive decay chains of heavier elements like uranium-235 ($^{235}$U), uranium-238 ($^{238}$U), and thorium-232 ($^{232}$Th). These decay chains are ubiquitous in rocks and soil globally. However, due to its very short half-lives (the most stable isotope, Astatine-210, has a half-life of approximately 8.1 hours), any astatine formed decays quickly, making its detection and isolation exceptionally challenging. It is uniformly distributed in extremely dilute concentrations across the globe wherever these parent radioisotopes are found, but not in any measurable or extractable amounts.
Lack of Common, Everyday Uses
Astatine has no common, everyday uses due to its extreme rarity, intense radioactivity, and very short half-life. Its fleeting existence and hazardous nature preclude any practical applications in household products, industrial materials, or consumer goods. The total amount of astatine ever isolated in macroscopic quantities is negligible, primarily for scientific study. Therefore, providing a list of five common, everyday uses is not possible, as such uses do not exist.
Specialized Applications and Research
Despite its extreme rarity and instability, astatine is a subject of ongoing scientific research due to its unique properties.
Medical Research: Targeted Alpha Therapy
The primary area of interest for astatine’s application is in medical research, particularly for cancer treatment known as Targeted Alpha Therapy (TAT).
- Mechanism: Astatine-211 ($^{211}$At) is an alpha-emitting radioisotope. Alpha particles deliver a high dose of radiation over a very short range (typically a few cell diameters). This characteristic makes $^{211}$At a promising candidate for selectively destroying cancerous cells while minimizing damage to surrounding healthy tissue.
- Targeting: Researchers are working on attaching $^{211}$At to biomolecules, such as antibodies or peptides, that specifically bind to receptors found on cancer cells. This allows for highly localized delivery of the radioactive payload.
- Global Research: Research into $^{211}$At for TAT is conducted in specialized medical and nuclear research centers worldwide, including institutions in the United States (e.g., National Cancer Institute, various university hospitals), Europe (e.g., comprehensive cancer centers in Germany, France, and Sweden), and Asia (e.g., research hospitals in Japan). These efforts aim to develop effective treatments for various cancers, including brain tumors and certain blood cancers.
Fundamental Scientific Research
Astatine is also used in fundamental scientific research to study its chemical and physical properties. Its position as the heaviest halogen allows scientists to explore relativistic effects on atomic structure and chemical bonding, which become significant for very heavy elements. These studies often require the synthesis of astatine isotopes in minute quantities for analysis.
Production and Handling
Astatine is not extracted from natural sources because of its extreme rarity and dispersed nature. Instead, it is almost exclusively produced synthetically in specialized nuclear research facilities.
Synthesis in Particle Accelerators
The primary method for producing astatine involves nuclear reactions in particle accelerators, specifically cyclotrons.
- Methodology: Bismuth-209 ($^{209}$Bi) targets are bombarded with energetic alpha particles (helium nuclei). This nuclear reaction creates astatine isotopes, predominantly Astatine-211 ($^{211}$At), along with neutrons.
- International Facilities: This highly specialized production occurs in facilities equipped with cyclotrons capable of accelerating alpha particles to the required energies. Examples include laboratories in the United States, such as the Department of Energy’s national laboratories, and European facilities like those associated with CERN or national nuclear research centers (e.g., in France, Germany, Sweden), as well as dedicated medical isotope production facilities in countries like Japan.
- Yields: Even with advanced cyclotrons, the quantities produced are typically in the microgram range, sufficient for research but far too little for widespread industrial application or everyday use.
Due to its high radioactivity and short half-life, astatine requires highly specialized containment and handling procedures to ensure the safety of personnel and the environment. Its “use in industry” is limited to its production for research purposes in these highly controlled environments.